Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists ...

The following guide offers a detailed overview of several classes of medications that research links to a higher risk of dementia. You will find what these drugs treat, the evidence connecting them to ...

Antipsychotic use in older adults in the US soared from 2015 to 2024, with a growing share coming from long-term care ...

Antipsychotics should not be routinely used to treat primary insomnia in children, adults, or the elderly, according to new recommendations issued by leading Canadian psychiatric organizations. This ...

Antipsychotic drugs treat schizophrenia, bipolar disorder, and other mental health disorders. They can ease your symptoms and help you avoid a relapse (when your symptoms come back), but they can also ...

Antipsychotics come from a long line of accidents. In 1876, German chemists created a textile dye called methylene blue, which happened to also dye cells. It meandered into biology labs and, soon ...

For patients in nursing homes, treatment with antipsychotic medicines is pretty much routine. Though the drugs were developed to treat schizophrenia, they're also used to manage the dementia-related ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

My first experience with antipsychotic medication was in the early 1960s, shortly after they were introduced. As is usual with new treatments, benefits were appreciated before harms were realized.

Doctors prescribe antipsychotic medications to treat psychosis. Mental health conditions like bipolar disorder and schizophrenia can include psychosis. Psychosis occurs when a person’s mental health ...

This is the latest, and perhaps last, of several debates with Bob Whitaker on the role of antipsychotics in treating psychotic symptoms. It was triggered by a recent email exchange that clarified our ...

In response to a generic question about post-market drug surveillance posed during a February 2007 House Energy and Commerce Committee hearing, Dr. David Graham, then associate director of science and ...